1. Home
  2. QLGN vs SCKT Comparison

QLGN vs SCKT Comparison

Compare QLGN & SCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • QLGN
  • SCKT
  • Stock Information
  • Founded
  • QLGN 1996
  • SCKT 1992
  • Country
  • QLGN United States
  • SCKT United States
  • Employees
  • QLGN N/A
  • SCKT N/A
  • Industry
  • QLGN Biotechnology: Pharmaceutical Preparations
  • SCKT Computer Manufacturing
  • Sector
  • QLGN Health Care
  • SCKT Technology
  • Exchange
  • QLGN Nasdaq
  • SCKT Nasdaq
  • Market Cap
  • QLGN 7.4M
  • SCKT 7.5M
  • IPO Year
  • QLGN N/A
  • SCKT 1995
  • Fundamental
  • Price
  • QLGN $3.06
  • SCKT $0.95
  • Analyst Decision
  • QLGN
  • SCKT
  • Analyst Count
  • QLGN 0
  • SCKT 0
  • Target Price
  • QLGN N/A
  • SCKT N/A
  • AVG Volume (30 Days)
  • QLGN 3.7M
  • SCKT 26.3K
  • Earning Date
  • QLGN 11-13-2025
  • SCKT 10-22-2025
  • Dividend Yield
  • QLGN N/A
  • SCKT N/A
  • EPS Growth
  • QLGN N/A
  • SCKT N/A
  • EPS
  • QLGN N/A
  • SCKT N/A
  • Revenue
  • QLGN N/A
  • SCKT $15,945,520.00
  • Revenue This Year
  • QLGN N/A
  • SCKT $8.62
  • Revenue Next Year
  • QLGN N/A
  • SCKT N/A
  • P/E Ratio
  • QLGN N/A
  • SCKT N/A
  • Revenue Growth
  • QLGN N/A
  • SCKT N/A
  • 52 Week Low
  • QLGN $1.61
  • SCKT $0.82
  • 52 Week High
  • QLGN $8.81
  • SCKT $1.72
  • Technical
  • Relative Strength Index (RSI)
  • QLGN 40.62
  • SCKT 39.94
  • Support Level
  • QLGN $2.90
  • SCKT $0.92
  • Resistance Level
  • QLGN $5.97
  • SCKT $1.01
  • Average True Range (ATR)
  • QLGN 0.54
  • SCKT 0.06
  • MACD
  • QLGN -0.20
  • SCKT -0.00
  • Stochastic Oscillator
  • QLGN 5.21
  • SCKT 52.10

About QLGN Qualigen Therapeutics Inc.

Qualigen Therapeutics Inc is an early-clinical-stage therapeutics company focused on developing treatments for adult and pediatric cancer. The company's business consists of one early-clinical-stage therapeutic program (QN-302) and one preclinical therapeutic program. The company's program, QN-302, is an investigational small-molecule G-quadruplexes (G4)-selective transcription inhibitor with binding affinity to G4s prevalent in cancer cells.

About SCKT Socket Mobile Inc.

Socket Mobile Inc is a producer of data capture products. The company's products are integrated into mobile applications used in mobile point of sale (mPOS), commercial services (field workers), asset tracking, manufacturing process and quality control, transportation and logistics (goods tracking and movement), event management (ticketing, entry, access control, and identification), medical and education. The company offers barcode scanning products for both one-dimensional, including imager and laser, and two-dimensional barcode scanning in standard and durable cases. The company's geographical segments are the Americas, Europe, Asia Pacific, and Africa, of which the majority of the revenue is generated from the United States.

Share on Social Networks: